Healthcare >> CEO Interviews >> May 13, 2003
KEVIN DeGEETER, Editor of FierceBiotech, has spent his career at
the intersection of biotechnology and finance. As the Editor of
FierceBiotech, he produces a free daily e-mail newsletter read by
more than 20,000 biotechnology and pharmaceutical industry
executives. Prior to joining FierceBiotech, he was Senior
Healthcare Writer for The Daily Deal, a daily newspaper targeting
investment bankers and venture capitalists. His stories have been
syndicated on CNBC.com, BioSpace.com and other financial
websites. During the late 1990s he conducted equity research for
Wall Street firms such as J.P. Morgan and PaineWebber. He is a
graduate of Colgate University with a degree in Economics and
currently lives in New York. In addition to his work with
FierceBiotech, he regularly writes profiles of biotechnology and
private equity executives for various print publications. Profile
TWST: Could you give us a quick overview of FierceBiotech?Mr. DeGeeter: FierceBiotech is a free daily e-mail distributed
newsletter providing an overview on the top biotech and